News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Handshake
ICR features in prestigious report on university-business collaboration

06/07/18

A new strategic partnership between The ICR, the pharma company Merck and Cancer Research UK features in a new report on effective collaborations between academics and industry partners.
Breast cancer cell timelapse
New ‘triple therapy’ could boost treatment and prevent relapse of advanced breast cancer

03/07/18

Treating advanced breast cancer with three drugs instead of one could boost the effectiveness of treatment and stop tumours developing resistance, a new study reports.
MRI brain scan
Teamwork between cells fuels aggressive childhood brain tumour

02/07/18

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study.
Histological slide showing prostate cancer 4.3 ratio
Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

27/06/18

A new form of immunotherapy reactivates the response to hormone treatment in advanced prostate cancer, a study in mice and human prostate cancer cells has found.
Pill bottle
ICR and partners take centre stage at major international conferences

26/06/18

Clinical trials of promising cancer treatments discovered or developed at the ICR were among the highlights at this year’s American Society of Clinical Oncology (ASCO) meeting, the biggest international clinical cancer research gathering of the year.
ICR Logo
Professor Mel Greaves awarded prestigious Society of Memorial Sloan Kettering Prize for contributions to childhood cancer

25/06/18

The ICR’s Professor Mel Greaves has been awarded a prestigious prize from the Memorial Sloan Kettering Cancer Center in New York for his ground-breaking research and expertise in childhood leukaemia.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
Higher BMI is associated with a lower risk of breast cancer before the menopause

21/06/18

Having a higher body mass index (BMI) at a younger age is associated with a decreased risk of developing breast cancer before the menopause, major new research funded by Breast Cancer Now and other collaborators has found.
U-Multirank logo
ICR ranked among the world’s best research institutions for industry collaboration

15/06/18

The ICR has ranked in the top 30 higher education institutions in the world for research in an independent evaluation funded by the European Commission.
ICR Logo
Gene testing could identify men with prostate cancer who may benefit from immunotherapy

14/06/18

Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.
Biopsy of lung adenocarcinoma tissue
Blocking energy production could help treat lung cancer where chemotherapy has limited effect

12/06/18

Targeting an enzyme that helps cells to generate energy could trigger cell death and be a way to treat some forms of lung cancer, even where the effect of chemotherapy is limited.
Prostate Gland
Prostate cancer DNA test identifies men with six-fold increased risk

11/06/18

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.
Abiraterone pills
The ICR responds to decision by NICE not to recommend abiraterone as first-line treatment for advanced prostate cancer

06/06/18

The Institute of Cancer Research, London, has expressed disappointment that the prostate cancer drug abiraterone (brand name Zytiga) will not be made available to men with advanced prostate cancer as a first-line treatment on the NHS.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.